Daito Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DAITO, and what generic and branded alternatives to DAITO drugs are available?
DAITO has two approved drugs.
Drugs and US Patents for Daito
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Daito | METHOTREXATE SODIUM | methotrexate sodium | TABLET;ORAL | 213362-001 | Aug 7, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Daito Pharms Co Ltd | RILUZOLE | riluzole | TABLET;ORAL | 204430-001 | Oct 16, 2018 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.